Tigecycline Injection, Powder, Lyophilized, For Solution
Product Images NDC 0781-3481

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tigecycline (NDC 0781-3481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tigecycline Chemical Structure (Tigecycline 01)

Chemical structure diagram of the active ingredient tigecycline, showing its molecular components and arrangement of atoms.*

FDA Label Image

10 mL Carton (Tigecycline 02)

Label for Tigecycline for Injection, USP 50 mg per vial, lyophilized powder for solution. The label indicates that the reconstituted solution must be further diluted for intravenous infusion. The package contains 10 single-dose vials of 50 mg each. The product is labeled by Sandoz Inc, a division of Novartis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.